Insmed (INSM) Operating Leases (2019 - 2026)

Insmed's Operating Leases history runs 8 years deep, the most recent figure standing at $9.8 million for Q1 2026.

• On a quarterly basis, Operating Leases rose 16.0% year-over-year to $9.8 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 16.0% increase from a year earlier, with the FY2025 full-year figure at $12.2 million, up 33.6% from the prior year.
• Operating Leases fell to $9.8 million in Q1 2026 per INSM's latest filing, from $12.2 million in the prior quarter.
• Across five years, Operating Leases topped out at $19.9 million in Q1 2022 and bottomed at $7.6 million in Q3 2025.
• The 5-year median for Operating Leases is $12.2 million (2025), against an average of $12.4 million.
• Biggest YoY gain for Operating Leases was 33.6% in 2025; the steepest drop was 38.59% in 2025.
• Year by year, Operating Leases stood at $14.9 million in 2022, then declined by 25.85% to $11.0 million in 2023, then decreased by 17.26% to $9.1 million in 2024, then soared by 33.6% to $12.2 million in 2025, then slipped by 19.2% to $9.8 million in 2026.
• Per Business Quant, the three latest INSM Operating Leases figures stand at $9.8 million (Q1 2026), $12.2 million (Q4 2025), and $7.6 million (Q3 2025).